These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9421472)

  • 1. Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.
    Crawley AC; Yogalingam G; Muller VJ; Hopwood JJ
    J Clin Invest; 1998 Jan; 101(1):109-19. PubMed ID: 9421472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild feline mucopolysaccharidosis type VI. Identification of an N-acetylgalactosamine-4-sulfatase mutation causing instability and increased specific activity.
    Yogalingam G; Hopwood JJ; Crawley A; Anson DS
    J Biol Chem; 1998 May; 273(22):13421-9. PubMed ID: 9593674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis VI in cats - clarification regarding genetic testing.
    Lyons LA; Grahn RA; Genova F; Beccaglia M; Hopwood JJ; Longeri M
    BMC Vet Res; 2016 Jul; 12(1):136. PubMed ID: 27370326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of mucopolysaccharidosis type VI mutations in Siamese cats.
    Crawley AC; Muntz FH; Haskins ME; Jones BR; Hopwood JJ
    J Vet Intern Med; 2003; 17(4):495-8. PubMed ID: 12892300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline mucopolysaccharidosis type VI. Characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease.
    Yogalingam G; Litjens T; Bielicki J; Crawley AC; Muller V; Anson DS; Hopwood JJ
    J Biol Chem; 1996 Nov; 271(44):27259-65. PubMed ID: 8910299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase.
    Litjens T; Hopwood JJ
    Hum Mutat; 2001 Oct; 18(4):282-95. PubMed ID: 11668612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feline mucopolysaccharidosis type VI: correction of glycosaminoglycan storage in myoblasts by retrovirus-mediated transfer of the feline N-acetylgalactosamine 4-sulfatase gene.
    Yogalingam G; Bielicki J; Hopwood JJ; Anson DS
    DNA Cell Biol; 1997 Oct; 16(10):1189-94. PubMed ID: 9364929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term intra-articular administration of recombinant human N-acetylgalactosamine-4-sulfatase in feline mucopolysaccharidosis VI.
    Auclair D; Hopwood JJ; Lemontt JF; Chen L; Byers S
    Mol Genet Metab; 2007 Aug; 91(4):352-61. PubMed ID: 17544310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations.
    Ruane T; Haskins M; Cheng A; Wang P; Aguirre G; Knox VW; Qi Y; Tompkins T; O'Neill CA
    Mol Genet Metab; 2016 Feb; 117(2):157-63. PubMed ID: 26776148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients.
    Litjens T; Brooks DA; Peters C; Gibson GJ; Hopwood JJ
    Am J Hum Genet; 1996 Jun; 58(6):1127-34. PubMed ID: 8651289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI.
    Evers M; Saftig P; Schmidt P; Hafner A; McLoghlin DB; Schmahl W; Hess B; von Figura K; Peters C
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8214-9. PubMed ID: 8710849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal granulation of blood granulocytes in mucopolysaccharidosis VI-a case report.
    Krishnagiri C; Ajanahalli RR; Kashyap S; Anegundi R; Boranaik L
    Ann Diagn Pathol; 2013 Feb; 17(1):137-9. PubMed ID: 22056033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-articular enzyme administration for joint disease in feline mucopolysaccharidosis VI: enzyme dose and interval.
    Auclair D; Hein LK; Hopwood JJ; Byers S
    Pediatr Res; 2006 Apr; 59(4 Pt 1):538-43. PubMed ID: 16549525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses.
    Simonaro CM; Haskins ME; Schuchman EH
    Lab Invest; 2001 Sep; 81(9):1319-28. PubMed ID: 11555679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network.
    Bradford TM; Litjens T; Parkinson EJ; Hopwood JJ; Brooks DA
    Biochemistry; 2002 Apr; 41(15):4962-71. PubMed ID: 11939792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry.
    Crawley A; Ramsay SL; Byers S; Hopwood J; Meikle PJ
    Pediatr Res; 2004 Apr; 55(4):585-91. PubMed ID: 14711884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI].
    Zheng J; Huang Y; Zhao X; Sheng H; Cheng J; Zhou Z; Li X; Mao X; Liu L
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):403-8. PubMed ID: 25190157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease.
    Walkley SU; Thrall MA; Haskins ME; Mitchell TW; Wenger DA; Brown DE; Dial S; Seim H
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):536-44. PubMed ID: 16150124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of residual arylsulfatase B activity in feline mucopolysaccharidosis VI by thiol-induced subunit association.
    Vine DT; McGovern MM; Schuchman EH; Haskins ME; Desnick RJ
    J Clin Invest; 1982 Feb; 69(2):294-302. PubMed ID: 6799547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic rescue after adeno-associated virus-mediated delivery of 4-sulfatase to the retinal pigment epithelium of feline mucopolysaccharidosis VI.
    Ho TT; Maguire AM; Aguirre GD; Surace EM; Anand V; Zeng Y; Salvetti A; Hopwood JJ; Haskins ME; Bennett J
    J Gene Med; 2002; 4(6):613-21. PubMed ID: 12439853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.